Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16522774rdf:typepubmed:Citationlld:pubmed
pubmed-article:16522774lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:16522774lifeskim:mentionsumls-concept:C0026922lld:lifeskim
pubmed-article:16522774lifeskim:mentionsumls-concept:C0023343lld:lifeskim
pubmed-article:16522774lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:16522774lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:16522774pubmed:issue3lld:pubmed
pubmed-article:16522774pubmed:dateCreated2006-3-8lld:pubmed
pubmed-article:16522774pubmed:abstractTextDespite the success of multidrug therapy in reducing the number of registered leprosy cases worldwide, evidence suggests that Mycobacterium leprae continues to be transmitted. A serological diagnostic test capable of identifying and allowing treatment of early-stage disease could reduce transmission and prevent the onset of the disability, a common complication of the disease in later stages. Serological diagnosis based on antibody recognition of phenolic glycolipid I (PGL-I) cannot reliably identify individuals with lower bacterial indices (BI). One strategy that might improve this situation is the provision of highly specific serological antigens that may be combined with PGL-I to improve the sensitivity of diagnosis. Using serological expression cloning with a serum pool of untreated lepromatous leprosy (LL) patients, we identified 14 strongly reactive M. leprae proteins, 5 of which were previously unstudied. We present results suggesting that two of these proteins, ML0405 and ML2331, demonstrate the ability to specifically identify LL/borderline lepromatous (BL) patients on the basis of immunoglobulin G (IgG) reactivity. In a household contact study, LL index cases were identified on the basis of this reactivity, while household contacts of these patients demonstrated undetectable reactivity. At a serum dilution of 1:800, suitable to reduce background PGL-I IgM reactivity, two BL patients with a BI of <4 showed anti-human polyvalent immunoglobulin G, A, and M reactivity measured with a combination of ML0405, ML2331, and natural disaccharide O-linked human serum albumin (NDOHSA) (synthetic PGL-I) that was markedly higher than IgM reactivity to NDOHSA alone. We suggest that ML0405 and ML2331 may have utility in serological leprosy diagnosis.lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:languageenglld:pubmed
pubmed-article:16522774pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:citationSubsetIMlld:pubmed
pubmed-article:16522774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16522774pubmed:statusMEDLINElld:pubmed
pubmed-article:16522774pubmed:monthMarlld:pubmed
pubmed-article:16522774pubmed:issn1556-6811lld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:SpencerJohnJlld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:ReedSteven...lld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:BrennanPatric...lld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:MohamathRaodo...lld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:GelberRobertRlld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:ReeceStephen...lld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:IretonGregGlld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:GuderianJeffr...lld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:GotoWakakoWlld:pubmed
pubmed-article:16522774pubmed:authorpubmed-author:GroathouseNat...lld:pubmed
pubmed-article:16522774pubmed:issnTypePrintlld:pubmed
pubmed-article:16522774pubmed:volume13lld:pubmed
pubmed-article:16522774pubmed:ownerNLMlld:pubmed
pubmed-article:16522774pubmed:authorsCompleteYlld:pubmed
pubmed-article:16522774pubmed:pagination333-40lld:pubmed
pubmed-article:16522774pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:meshHeadingpubmed-meshheading:16522774...lld:pubmed
pubmed-article:16522774pubmed:year2006lld:pubmed
pubmed-article:16522774pubmed:articleTitleML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.lld:pubmed
pubmed-article:16522774pubmed:affiliationIDRI, 1124 Columbia Street, Suite 400, Seattle, WA 98104, USA. sreed@idri.orglld:pubmed
pubmed-article:16522774pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16522774pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16522774lld:pubmed